Zwick et al, Trends in Molecular Medicine (2002) 8: 17-23
MONOCLONAL ANTIBODIES AS ANTI- TYROSINE KINASE RECEPTOR  DRUGS
Anti-RTK mAbs block the ligand-receptor interaction
ð inhibition of ligand-induced RTK signaling
ð increase of RTK down regulation and internalization
2003-2004